Genmab Commences New Arbitration Under License Agreement With Janssen
9/6 23:17
Company Announcement COPENHAGEN , Denmark; June 9 , 20 2 2 – Genmab A/S ( Nasdaq: GMAB ) announced today that it has commenced a new arbitration under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab. This new arbitration follows from the award in the prior arbitration,...